10-Q
XBRL
BIOTIME, INC. 10-Q 6-30-2016
- Company
- Lineage Cell Therapeutics, Inc.
- Filed
- August 9, 2016
- Period of Report
- June 30, 2016
- Accession Number
- 0001140361-16-075508
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →